NOCT and lung carcinoma: Regarding lung cancer, it is reported that in clinical samples from SCC, the expression of PARN, CNOT6, and Nocturnin is associated with overall survival, while CNOT6 overexpression is a strong indicator against metastasis, thus highlighting deadenylases as promising survival and prognostic factors in lung cancer [27].